首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection
【24h】

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection

机译:蛋白酶介导的严重急性呼吸综合征冠状病毒感染的增强

获取原文
获取原文并翻译 | 示例
           

摘要

A unique coronavirus severe acute respiratory syndrome-coronavirus (SARS-CoV) was revealed to be a causative agent of a life-threatening SARS. Although this virus grows in a variety of tissues that express its receptor, the mechanism of the severe respiratory illness caused by this virus is not well understood. Here, we report a possible mechanism for the extensive damage seen in the major target organs for this disease. A recent study of the cell entry mechanism of SARS-CoV reveals that it takes an endosomal pathway. We found that proteases such as trypsin and thermolysin enabled SARS-CoV adsorbed onto the cell surface to enter cells directly from that site. This finding shows that SARS-CoV has the potential to take two distinct pathways for cell entry, depending on the presence of proteases in the environment. Moreover, the protease-mediated entry facilitated a 100- to 1,000-fold higher efficient infection than did the endosomal pathway used in the absence of proteases. These results suggest that the proteases produced in the lungs by inflammatory cells are responsible for high multiplication of SARS-CoV, which results in severe lung tissue damage. Likewise, elastase, a major protease produced in the lungs during inflammation, also enhanced SARS-CoV infection in cultured cells.
机译:独特的冠状病毒严重急性呼吸综合征-冠状病毒(SARS-CoV)被发现是威胁生命的SARS的病原。尽管该病毒在表达其受体的各种组织中生长,但对该病毒引起的严重呼吸道疾病的机制尚不十分了解。在这里,我们报告了这种疾病在主要靶器官中看到的广泛损害的可能机制。对SARS-CoV细胞进入机制的最新研究表明,它采取了内体途径。我们发现蛋白酶(例如胰蛋白酶和嗜热菌蛋白酶)可使SARS-CoV吸附到细胞表面,从而直接从该位点进入细胞。这一发现表明,SARS-CoV有可能采取两种不同的途径进入细胞,具体取决于环境中蛋白酶的存在。而且,蛋白酶介导的进入比不存在蛋白酶时所用的内体途径促成有效感染高100至1,000倍。这些结果表明,炎性细胞在肺中产生的蛋白酶与SARS-CoV的高度繁殖有关,导致严重的肺组织损伤。同样,弹性蛋白酶是发炎过程中在肺部产生的一种主要蛋白酶,也增强了培养细胞中的SARS-CoV感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号